regarding drug pricing and the move by Massachusetts Attorney General

Link: http://www.statnews.com/pharmalot/2016/02/02/maura-healey-drug-prices/

——————–

Regarding the widely-questionned threat by the Attorney General of
Massachusetts to sue Gilead for pricing its Hep-C product “too high”:

“I don’t know of any state unfair trade practices law that gives a state
the right to regulate [drug] prices,” said Erik Gordon, a business and law
professor at the University of Michigan. Moreover, as he and other legal
experts wonder: How high is too high?

Suing over drug prices, although a clever ploy, is unlikely to succeed


_____________________
Erik Gordon
Ross School of Business
University of Michigan
Ann Arbor, Michigan

Leave a comment